Sourced from:Manufacturer Authorized Distributor
Quick Summary
Lomocare 40mg Injection
Last updated on 05 Aug 2026 | 07:09 AM (IST)
₹337
MRP: ₹481.56
(You Save ₹144.56)
1 PREFILLED SYRINGE(s) OF 0.4ML
Sourced from:Manufacturer Authorized Distributor
30% OFF
₹337
MRP: ₹481.56
Inclusive of all taxes
30% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Exhep 40mg Injection
EMCURE PHARMACE...
₹ 212.00/injection
37% cheaper
Enoxatil 40mg Injection
BIOLOGICAL E LT...
₹ 239.00/injection
29% cheaper
Cutenox 40mg Injection
GLAND PHARMA LT...
₹ 244.00/injection
27% cheaper
Evaparin 40mg Injection
INTAS PHARMACEU...
₹ 258.00/injection
23% cheaper
Introduction to Lomocare 40mg Injection
Lomocare 40mg Injection is an anticoagulant drug belonging to the category of low molecular weight heparin (LMWH). It contains the active ingredient Enoxaparin. It is used to treat severe blood clots. This drug also prevents the occurrence of deep vein thrombosis in abdominal surgery, hip replacement surgery, knee replacement surgery, and in people with severe movement restrictions. This injection prevents further heart complications in patients with unstable angina and non-Q wave myocardial infarction.
Lomocare 40mg Injection is not recommended for patients with active bleeding, hypersensitivity, or allergies to the active compound, as well as those with a history of heparin-induced thrombocytopenia before taking Lomocare 40mg Injection, tell your physician if you are allergic to Enoxaparin, heparin, benzyl alcohol, or pork products.
Your healthcare provider will regularly monitor you for signs of bleeding. Inform your healthcare practitioner if you are diagnosed with kidney problems. It is not recommended for use in children and adolescents below 18 years.
Lomocare 40mg Injection is not recommended if you undergo procedures like neuraxial anaesthesia or spinal puncture. It is recommended to monitor older adults and patients with low weight for increased risk of bleeding.
Tell your physician if you suspect pregnancy, breastfeeding, or planning to have a baby. Lomocare 40mg Injection may increase the chance of bleeding in pregnant women with artificial heart valves, and hence, close monitoring must be done.
Consult your doctor for more advice before starting Lomocare 40mg Injection medication, it is recommended not to take any hemostatic drugs unless absolutely necessary. It is needed to inform your physician about all the drugs you are taking, including herbal and vitamin supplements.
Uses of Lomocare 40mg Injection
Lomocare 40mg Injection is used in the treatment of the following:
- Deep vein thrombosis
- Prophylaxis of venous thrombo-embolism
- Unstable angina
- ST-segment Elevation Myocardial Infarction (STEMI)
- Prevention of blood clots during surgeries
Therapeutic Effects of Lomocare 40mg Injection
Lomocare 40mg Injection binds to the antithrombin to form a complex. Antithrombin is a protein that blocks the formation of abnormal blood clots. This drug mainly prevents the activation of factor Xa, eventually preventing clot formation. It is commonly used for the prevention and treatment of conditions associated with increased risk of blood clots.
Interaction of Lomocare 40mg Injection with other drugs
Some medicinal products that affect haemostasis should be discontinued before starting Lomocare 40mg Injection therapy unless absolutely necessary. If a combination is required, Lomocare 40mg Injection should be used with careful clinical and laboratory monitoring.
These products include systemic salicylates, acetylsalicylic acid at anti-inflammatory doses, NSAIDs like ketorolac, other thrombolytics such as alteplase, reteplase, streptokinase, tenecteplase, urokinase, and other anticoagulants.
Always inform your doctor about any medicines or supplements you are taking, as they may interact with Lomocare 40mg Injection.
More Information about Lomocare 40mg Injection
- Store Lomocare 40mg Injection below 25 °C.
- Do not freeze
- Keep it out of reach from children.
- Protect them from light and moisture.
How to consume Lomocare 40mg Injection
Lomocare 40mg Injection will be administered to you by a healthcare professional in a hospital setting. It is usually administered as an intravenous injection into a vein. Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.
Safety Advice for Lomocare 40mg Injection
Breast Feeding
It is unknown if Lomocare 40mg Injection is excreted unaltered in breast milk. Please consult your doctor before breastfeeding.
Alcohol
It is unknown if consuming alcoholic beverages while taking Lomocare 40mg Injection is safe. Please consult with your physician.
Liver
Inform your doctor if you have liver disease because of Lomocare 40mg Injection should be used cautiously with a liver condition.
Lungs
It is unknown whether Lomocare 40mg Injection is safe for patients with lung problems. Consult your doctor if you have lung disease before starting the treatment.
Driving
It is safe to travel, drive a car, or operate heavy machinery after receiving Lomocare 40mg Injection. Lomocare 40mg Injection does not impair alertness or coordination.
Pregnancy
Before beginning therapy with Lomocare 40mg Injection, tell your doctor if you are pregnant, suspect you are pregnant, or are planning to become pregnant. It is not known that Lomocare 40mg Injection interferes with pregnancy.
Side Effects of Lomocare 40mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious side effects of Lomocare 40mg Injection are:
- Severe allergic reactions (swelling of lips, tongue, or throat, difficulty breathing, or swallowing)
- Too much bleeding (weakness, being pale, dizziness with headache, or unexplained swelling)
- Blockage of blood vessels (pain, redness, or swelling in the legs, or coughing up blood)
- Rash of dark red spots under the skin
Common side effects of Lomocare 40mg Injection are:
- Bleeding
- Bruising more easily
- Low blood cell counts
- Headache
- Itchy red skin
- Edema
- Pain at the injection site
- Pink patches on the skin
Word of Advice
Lomocare 40mg Injection can cause bleeding and many undesirable side effects; hence it is advised to get adequate rest during the treatment. Eat a well-balanced diet. Apply a cool compress at the injection site to reduce pain and irritation. Lomocare 40mg Injection should not be stopped suddenly without first talking to your doctor because doing so may raise your risk of blood clots.
Aspirin and other non-steroidal anti-inflammatory medicines (NSAIDs) may increase the risk of bleeding when combined with Lomocare 40mg Injection, so it is not recommended to take them without first talking to your doctor. Keep away from activities that put you at higher risk of bleeding or getting hurt, like contact sports and activities.
Foods high in Vitamin K may have an impact on blood clotting and may interfere with the way anticoagulant drugs like Lomocare 40mg Injection. It is recommended to eat leafy green vegetables, asparagus, Brussels sprouts and soybean oil in moderation. It is advised to monitor your platelet count regularly.
FAQs about Lomocare 40mg Injection
Q1.
Who should not take Lomocare 40mg injection?
Lomocare 40mg Injection is not recommended for people suffering from active major bleeding or a history of hypersensitivity to Lomocare 40mg Injection, heparin, Benzyl alcohol, or pork products. This drug is also not advised for people with a history of heparin-induced thrombocytopenia in the past hundred days.
Q2.
What should you not take with Lomocare 40mg injection?
When taking Lomocare 40mg Injection, it's important to avoid certain medications, supplements, and activities that may increase the risk of bleeding or interact with the anticoagulant effects of Lomocare 40mg Injection includes other anticoagulants, non-steroidal anti-inflammatory drugs, and anti-platelets.
Q3.
Are there any most common side effects of Lomocare 40mg injection?
The most common adverse reactions of Lomocare 300mg injection are bleeding, anemia, thrombocytopenia, diarrhea, nausea, fever, edema, breathlessness, confusion, and pain at the injection site.
Q4.
What is the recommended duration for Lomocare 40mg Injection treatment?
The duration of Lomocare 40mg Injection treatment depends on the underlying condition being treated, the risk of clotting, and individual patient factors. Treatment may be short-term (e.g., during hospitalisation or surgical procedures) or long-term for chronic conditions such as DVT or PE.
Q5.
When should you report to the doctor while using Lomocare 40mg Injection?
Contact your physician directly if you experience severe allergic reactions like the spelling of lips, tongue, throat, difficulty breathing or swallowing, unexplained swelling, painful Rash, chest pain, or blood in the cough during the treatment with Lomocare 40mg Injection.
Q6.
What is the proper storage method for Lomocare 40mg Injection?
Lomocare 40mg Injection should be stored at room temperature (between 68°F to 77°F or 20°C to 25°C) away from light and moisture. It should be kept out of the reach of children and not be frozen. Unused portions of Lomocare 40mg Injection solution should be discarded according to the manufacturer's instructions.
Fact Box of Lomocare 40mg Injection
Molecule Name: Enoxaparin | Therapeutic class: Anticoagulant |
Pharmacological class: Low molecular weight heparin (LMWH) | Indications: Treat and prevent blood clot |
References
- Rovi Biotech Limited, Electronic Medicines Compendium (EMC), [Revised on Nov 2018], [Accessed on 27th May 2023], https://www.medicines.org.uk/emc/files/pil.9330.pdf
- Sanofi, [Revised on Apr 2022] [Accessed on 27th May 2023], https://products.sanofi.us/lovenox/lovenox.pdf
- Clexane® syringes 100mg/ml solution for Injection - HPRA. [Revised on May 2022], [Accessed on 27th May 2023], https://www.hpra.ie/img/uploaded/swedocuments/7900ad74-3eb7-41a2-be4c-3b757cb841ec.pdf
- KD Tripathi, Essentials of Medical Pharmacology, Drugs Affecting Coagulation, Bleeding and Thrombosis, 8th Edition, 2019, 659-681.
- https://www.ema.europa.eu/en/documents/product-information/inhixa-epar-product-information_en.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. B. Deiva
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 05 Aug 2026 | 07:09 AM (IST)
Want to know more?
Read Our Editorial Policy
